Differentiation syndrome with lower‐intensity treatments for acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Differentiation syndrome with lower‐intensity treatments for acute myeloid leukemia

Published:2021-03-18 Issue:6 Volume:96 Page:735-746
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Fathi Amir T.¹²^ORCID,Stein Eytan M.³⁴,DiNardo Courtney D.⁵^ORCID,Levis Mark J.⁶^ORCID,Montesinos Pau⁷^ORCID,Botton Stéphane⁸^ORCID

Affiliation:

1. Massachusetts General Hospital Cancer Center Boston Massachusetts USA

2. Harvard Medical School Boston Massachusetts USA

3. Memorial Sloan Kettering Cancer Center New York New York USA

4. Weill Cornell Medical College New York New York USA

5. The University of Texas MD Anderson Cancer Center Houston Texas USA

6. Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University Baltimore Maryland USA

7. Hospital Universitari I Politecnic La Fe Valencia Spain

8. Gustave Roussy Villejuif France

Funder

Bristol-Myers Squibb

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26142

Reference97 articles.

1. Acute Myeloid Leukemia

2. Targeting IDH Mutations in AML: Wielding the Double-edged Sword of Differentiation

3. FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions

4. Hypomethylating Agents as a Therapy for AML

5. Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-120

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemia;Blood Advances;2024-05-21

2. Differentiation syndrome associated with treatment with IDH2 inhibitor enasidenib: pooled analysis from clinical trials;Blood Advances;2024-05-21

3. Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors;Current Treatment Options in Oncology;2024-05-02

4. Sweet syndrome induced by FLT3 inhibitors: case report and literature review;Hematology;2024-04-02

5. Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation;Oncology and Therapy;2024-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3